A Single Arm Trial Evaluating the BARD Lutonix Drug-Coated Balloon (LTX DCB) for Treatment of Femoropopliteal Arteries

A trial with no phase registered on ClinicalTrials.gov. The registry status is completed. It enrolled 148 participants.

Also called NCT02720003

  • Study
  • In this atlas

Overview

Design
Interventional study; allocation not applicable; no masking; primary purpose treatment
Phase
Not applicable
Enrolled
  • 148 participants (enrolled count) (from the registry)
Sponsor
  • C. R. Bard Registry lists this organization as the lead sponsor
Registry
  • NCT NCT02720003
Start date
(registry gives no type) (from the registry)
Primary completion
(actual) (from the registry)
Completion
(actual) (from the registry)
Countries
China (from the registry)
Registry status
  • Completed (from the registry)

Technical summary

Registry record NCT02720003. Allocation not applicable; no masking; primary purpose treatment. Start 2016-03 (registry gives no type); primary completion 2018-10 (actual). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
A Single Arm Trial Evaluating the BARD Lutonix Drug-Coated Balloon (LTX DCB) for Treatment of Femoropopliteal Arteries
Condition
Femoral Artery Stenosis
Condition
Femoral Artery Occlusion
Condition
Stenosis of Popliteal Arteries
Condition
Occlusion of Popliteal Arteries
Intervention (Device)
LTX DCB
Lead sponsor
C. R. Bard (class: industry)

Record details

Record id
cardio:ct-nct02720003
Content hash
47a6c92a601c5a418d34aa9f3b9b551c4942fda2a00dbf7398e980bf0f204c00